CLINICAL_TRIALS
trial_result
· 2022-01-13
Clinical Trial Update: MMR at 6 Months Trial [Phase 4]
Summary
A Phase 4 clinical trial update for the measles-mumps-rubella vaccine completed its study.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Rigshospitalet, Denmark | Conditions: Meales-mumps-rubella Vaccine | Phase 4 | Status: COMPLETED